$CVS
CVS HEALTH Corp Stock $cvs

$cvs Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000006480319000021 Filed on May 01, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$61.65B	$45.74B
YoY Change	34.77%	2.75%
Cost Of Revenue	$37.25B	$37.51B
YoY Change	-0.69%	-1.15%
Gross Profit	$24.40B	$8.238B
YoY Change	196.18%	25.37%
Gross Profit Margin	39.58%	18.01%
Selling, General & Admin	$8.142B	$4.913B
YoY Change	65.72%	2.83%
% of Gross Profit	33.37%	59.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.111B	$644.0M
YoY Change	72.52%
% of Gross Profit	4.55%	7.82%
Operating Expenses	$8.250B	$4.913B
YoY Change	67.92%	2.83%
Operating Profit	$2.690B	$1.996B
YoY Change	34.77%	10.95%
Interest Expense	$782.0M	$523.0M
YoY Change	49.52%	-307.54%
% of Operating Profit	29.07%	26.2%
Other Income/Expense, Net	$31.00M	$3.000M
YoY Change	933.33%	-142.86%
Pretax Income	$1.939B	$1.470B
YoY Change	31.9%	-4.17%
Income Tax	$512.0M	$472.0M
% Of Pretax Income	26.41%	32.11%
Net Earnings	$1.421B	$998.0M
YoY Change	42.38%	4.83%
Net Earnings / Revenue	2.31%	2.18%
Basic Earnings Per Share	$1.09	$0.98
Diluted Earnings Per Share	$1.09	$0.98
COMMON SHARES
Basic Shares Outstanding	1.298B shares	1.016B shares
Diluted Shares Outstanding	1.302B shares	1.019B shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.322B	$42.14B
YoY Change	-80.25%	1730.67%
Cash & Equivalents	$5.896B	$42.26B
Short-Term Investments	$2.426B	$119.0M
Other Short-Term Assets	$4.533B	$868.0M
YoY Change	422.24%	18.1%
Inventory	$15.45B	$14.82B
Prepaid Expenses
Receivables	$19.51B	$13.96B
Other Receivables	$868.0M	$0.00
Total Short-Term Assets	$45.20B	$71.80B
YoY Change	-37.05%	143.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.36B	$10.14B
YoY Change	11.99%	0.87%
Goodwill	$79.08B
YoY Change
Intangibles	$36.31B
YoY Change
Long-Term Investments	$16.41B
YoY Change
Other Assets	$4.525B	$1.694B
YoY Change	167.12%	12.71%
Total Long-Term Assets	$171.5B	$63.34B
YoY Change	170.71%	0.2%
TOTAL ASSETS
Total Short-Term Assets	$45.20B	$71.80B
Total Long-Term Assets	$171.5B	$63.34B
Total Assets	$216.7B	$135.1B
YoY Change	60.33%	45.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.82B	$18.98B
YoY Change	41.28%	13.01%
Accrued Expenses	$10.66B	$7.724B
YoY Change	38.0%	-11.01%
Deferred Revenue	$75.00M
YoY Change
Short-Term Debt	$3.005B	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$1.267B	$3.542B
YoY Change	-64.23%	8137.21%
Total Short-Term Liabilities	$45.76B	$30.25B
YoY Change	51.29%	10.85%
LONG-TERM LIABILITIES
Long-Term Debt	$71.35B	$61.55B
YoY Change	15.91%	140.23%
Other Long-Term Liabilities	$2.262B	$1.604B
YoY Change	41.02%	-5.87%
Total Long-Term Liabilities	$73.61B	$63.16B
YoY Change	16.55%	131.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.76B	$30.25B
Total Long-Term Liabilities	$73.61B	$63.16B
Total Liabilities	$157.9B	$96.47B
YoY Change	63.73%	63.97%
SHAREHOLDERS EQUITY
Retained Earnings	$41.09B
YoY Change
Common Stock	$17.00M	$17.00M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$28.22B
YoY Change
Treasury Stock Shares	424.0M shares
Shareholders Equity	$58.40B	$38.67B
YoY Change
Total Liabilities & Shareholders Equity	$219.8B	$135.1B
YoY Change	62.62%	45.83%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$1.421B	$998.0M
YoY Change	42.38%	4.83%
Depreciation, Depletion And Amortization	$1.111B	$644.0M
YoY Change	72.52%
Cash From Operating Activities	$1.948B	$2.355B
YoY Change	-17.28%	-33.34%
INVESTING ACTIVITIES
Capital Expenditures	$716.0M	$482.0M
YoY Change	48.55%	-205.47%
Acquisitions	$124.0M	$353.0M
YoY Change	-64.87%
Other Investing Activities	-$10.00M	$2.000M
YoY Change	-600.0%	-102.5%
Cash From Investing Activities	-$891.0M	-$131.0M
YoY Change	580.15%	-75.61%
FINANCING ACTIVITIES
Cash Dividend Paid	$649.0M	$508.0M
YoY Change	27.76%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$882.0M	$1.000M
YoY Change	88100.0%
Cash From Financing Activities	$816.0M	$38.14B
YoY Change	-97.86%	-1022.82%
NET CHANGE
Cash From Operating Activities	$1.948B	$2.355B
Cash From Investing Activities	-$891.0M	-$131.0M
Cash From Financing Activities	$816.0M	$38.14B
Net Change In Cash	$1.873B	$40.36B
YoY Change	-95.36%	-3650.04%
FREE CASH FLOW
Cash From Operating Activities	$1.948B	$2.355B
Capital Expenditures	$716.0M	$482.0M
Free Cash Flow	$1.232B	$1.873B
YoY Change	-34.22%	-53.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	cvs	Deferredincometaxesandothernoncashitems Deferredincometaxesandothernoncashitems	153000000	USD
CY2019Q1	cvs	Numberof Patients Servedper Year NumberofPatientsServedperYear	1000000	patient
CY2019Q1	cvs	Adjusted Operating Income Loss AdjustedOperatingIncomeLoss	3595000000	USD
CY2019Q1	cvs	Contractwith Customer Liaiblity Redemptionand Breakage ContractwithCustomerLiaiblityRedemptionandBreakage	-82000000	USD
CY2018Q1	cvs	Deferredincometaxesandothernoncashitems Deferredincometaxesandothernoncashitems	62000000	USD
CY2018	cvs	Loss Contingency Audit Methodology Sample Size LossContingencyAuditMethodologySampleSize	200	memeber
CY2015Q3	cvs	Loss Contingency Number Of Locations With Subpoena For Documents LossContingencyNumberOfLocationsWithSubpoenaForDocuments	8	store
CY2019Q1	cvs	Noncontrollinginterest Other Period Increase Decrease NoncontrollinginterestOtherPeriodIncreaseDecrease	-4000000	USD
CY2018Q1	cvs	Adjusted Operating Income Loss AdjustedOperatingIncomeLoss	2293000000	USD
CY2019Q1	cvs	Finance Lease Cost FinanceLeaseCost	19000000	USD
CY2019Q1	cvs	Guarantor Obligations Numberof Leases GuarantorObligationsNumberofLeases	80	store
CY2018Q1	cvs	Investment Income Excluding Capital Gainsor Losses InvestmentIncomeExcludingCapitalGainsorLosses	50000000	USD
CY2019Q1	cvs	Investment Income Excluding Capital Gainsor Losses InvestmentIncomeExcludingCapitalGainsorLosses	190000000	USD
CY2019Q1	cvs	Lease Liability LeaseLiability	21324000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due LesseeLiabilityPaymentsDue	29308000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due After Year Five LesseeLiabilityPaymentsDueAfterYearFive	17374000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due Year Five LesseeLiabilityPaymentsDueYearFive	2259000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due Year Four LesseeLiabilityPaymentsDueYearFour	2374000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due Year Three LesseeLiabilityPaymentsDueYearThree	2539000000	USD
CY2019Q1	cvs	Lessee Liability Payments Due Year Two LesseeLiabilityPaymentsDueYearTwo	2677000000	USD
CY2019Q1	cvs	Lessee Liability Payments Remainderof Fiscal Year LesseeLiabilityPaymentsRemainderofFiscalYear	2085000000	USD
CY2019Q1	cvs	Lessee Liability Undiscounted Excess Amount LesseeLiabilityUndiscountedExcessAmount	7984000000	USD
CY2019Q1	cvs	Numberof People Servedthrough Health Insurance Productsand Related Services NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices	38000000	person
CY2019Q1	cvs	Numberof Pharmacy Plan Members NumberofPharmacyPlanMembers	94000000	Plans
CY2019Q1	cvs	Numberof Walk In Medical Clinics NumberofWalkInMedicalClinics	1100	clinic
CY2019Q1	cvs	Operating And Capital Leases Amount Due In Excess Of Remaining Estimated Economic Life OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife	2100000000	USD
CY2018Q4	cvs	Other Insurance Liabilities Current OtherInsuranceLiabilitiesCurrent	1937000000	USD
CY2019Q1	cvs	Other Insurance Liabilities Current OtherInsuranceLiabilitiesCurrent	1937000000	USD
CY2018Q4	cvs	Other Insurance Liabilities Noncurrent OtherInsuranceLiabilitiesNoncurrent	8119000000	USD
CY2019Q1	cvs	Other Insurance Liabilities Noncurrent OtherInsuranceLiabilitiesNoncurrent	8052000000	USD
CY2018Q1	cvs	Paymentsfor Insurance Benefits PaymentsforInsuranceBenefits	-1093000000	USD
CY2019Q1	cvs	Paymentsfor Insurance Benefits PaymentsforInsuranceBenefits	-12951000000	USD
CY2018Q1	cvs	Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies	-35102000000	USD
CY2019Q1	cvs	Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies	-35645000000	USD
CY2018Q4	cvs	Pharmacy Claimsand Discounts Payable Current PharmacyClaimsandDiscountsPayableCurrent	11365000000	USD
CY2019Q1	cvs	Pharmacy Claimsand Discounts Payable Current PharmacyClaimsandDiscountsPayableCurrent	11827000000	USD
CY2019Q1	cvs	Premium Deficiency Reserve Liability PremiumDeficiencyReserveLiability	11000000	USD
CY2018Q4	cvs	Short Duration Liabilityfor Unpaid Claims Health Care ShortDurationLiabilityforUnpaidClaimsHealthCare	6143000000	USD
CY2019Q1	cvs	Short Duration Liabilityfor Unpaid Claims Health Care ShortDurationLiabilityforUnpaidClaimsHealthCare	6696000000	USD
CY2018Q1	cvs	Store Rationalization Charges StoreRationalizationCharges	0	USD
CY2019Q1	cvs	Store Rationalization Charges StoreRationalizationCharges	135000000	USD
CY2017Q4	cvs	Treasury Stock Shares Heldin Trust TreasuryStockSharesHeldinTrust	1000000	shares
CY2018Q1	cvs	Treasury Stock Shares Heldin Trust TreasuryStockSharesHeldinTrust	1000000	shares
CY2018Q4	cvs	Treasury Stock Shares Heldin Trust TreasuryStockSharesHeldinTrust	1000000	shares
CY2019Q1	cvs	Treasury Stock Shares Heldin Trust TreasuryStockSharesHeldinTrust	1000000	shares
CY2018Q1	cvs	Treasury Stock Value Acquired Cost Method Net Of Espp Issuance TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance	-49000000	USD
CY2019Q1	cvs	Treasury Stock Value Acquired Cost Method Net Of Espp Issuance TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance	-7000000	USD
CY2017Q4	cvs	Treasury Stock Value Shares Held In Trust TreasuryStockValueSharesHeldInTrust	31000000	USD
CY2018Q1	cvs	Treasury Stock Value Shares Held In Trust TreasuryStockValueSharesHeldInTrust	31000000	USD
CY2018Q4	cvs	Treasury Stock Value Shares Held In Trust TreasuryStockValueSharesHeldInTrust	29000000	USD
CY2019Q1	cvs	Treasury Stock Value Shares Held In Trust TreasuryStockValueSharesHeldInTrust	29000000	USD
CY2018Q4	cvs	Vendorand Manufacturer Receivables VendorandManufacturerReceivables	7655000000	USD
CY2019Q1	cvs	Vendorand Manufacturer Receivables VendorandManufacturerReceivables	8901000000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000064803
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1299092100	shares
CY2019Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	CVS HEALTH CORPORATION /DE/
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	8925000000	USD
CY2019Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	8290000000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17631000000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19509000000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10711000000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10443000000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10659000000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	102000000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	433000000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	210000000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	622000000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13200000	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15300000	shares
CY2018Q4	us-gaap	Assets Assets	196456000000	USD
CY2019Q1	us-gaap	Assets Assets	219768000000	USD
CY2019Q1	us-gaap	Assets Assets	216668000000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	45243000000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	47857000000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	45195000000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	15335000000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	2991000000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5511000000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	3510000000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	990000000	USD
CY2018Q1	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	1.40
CY2018Q1	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	1.39
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1807000000	USD
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	59093000000	USD
CY2018Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	43000000	USD
CY2019Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	148000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4059000000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5896000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1900000000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42264000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4295000000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6168000000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40364000000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1873000000	USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3200000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1720000000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1722000000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1295000000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1298000000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2018Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	45440000000	USD
CY2019Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	45615000000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1342000000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1752000000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1342000000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1758000000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	6896000000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	7158000000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	90000000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	67000000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	75000000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37505000000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37247000000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	43747000000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	58956000000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-13000000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	178000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7677000000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7540000000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7740000000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	644000000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1111000000	USD
CY2018Q1	us-gaap	Dividends Common Stock DividendsCommonStock	508000000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	651000000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10000000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	10000000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	560000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	25000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	535000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1077000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	786000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	56000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	58000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	62000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	65000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	50000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	517000000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	509000000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	9000000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	Rate
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P20Y3M18D
CY2018Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	86000000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	78678000000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	79075000000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	996000000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1419000000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1470000000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1939000000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472000000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	512000000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-53000000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-53000000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-178000000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22000000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-857000000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1989000000	USD
CY2018Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	236000000	USD
CY2019Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	553000000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	464000000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1001000000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-57000000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-389000000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	988000000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-11000000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3000000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4000000	shares
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	36524000000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35147000000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	36307000000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	523000000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	782000000	USD
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-42000000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	545000000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	1123000000	USD
CY2019Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	18000000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	16450000000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	15448000000	USD
CY2018Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	50000000	USD
CY2019Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	199000000	USD
CY2018Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2019Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9000000	USD
CY2018Q1	us-gaap	Investment Income Net InvestmentIncomeNet	50000000	USD
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	249000000	USD
CY2018Q4	us-gaap	Investments Investments	18254000000	USD
CY2019Q1	us-gaap	Investments Investments	18836000000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	837000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28231000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	16588000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2203000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2316000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2477000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2612000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2035000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7467000000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	137913000000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	159762000000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	157947000000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	196456000000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	219768000000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44009000000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	50631000000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	45762000000	USD
CY2019Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	8004000000	USD
CY2019Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	4812000000	USD
CY2019Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	13358000000	USD
CY2018Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	6147000000	USD
CY2019Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	6701000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1265000000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3893000000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1267000000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	71444000000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	67888000000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	71348000000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	15732000000	USD
CY2019Q1	us-gaap	Long Term Investments LongTermInvestments	16410000000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	318000000	USD
CY2019Q1	us-gaap	Minority Interest MinorityInterest	320000000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38140000000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	816000000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-131000000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-891000000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2355000000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1948000000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6000000	USD
CY2018Q1	us-gaap	Net Investment Income NetInvestmentIncome	50000000	USD
CY2019Q1	us-gaap	Net Investment Income NetInvestmentIncome	249000000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	Segment
CY2019Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	4	state
CY2019Q1	us-gaap	Number Of Stores NumberOfStores	9900	building
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	4913000000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	8250000000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1996000000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2690000000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	682000000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	20764000000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1803000000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1803000000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18961000000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18832000000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	670000000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20992000000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20987000000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	Rate
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y2M12D
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	182000000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4581000000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4578000000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4533000000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5046000000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4865000000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4525000000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	334000000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	343000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-4000000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	344000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	331000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2780000000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2616000000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2262000000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-31000000	USD
CY2018Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2939000000	USD
CY2019Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2732000000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	821000000	USD
CY2019Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	868000000	USD
CY2018Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	7000000	USD
CY2018Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-2000000	USD
CY2019Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-2000000	USD
CY2019Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	12816000000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	446000000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	0	USD
CY2018Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2000000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10000000	USD
CY2018Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	508000000	USD
CY2019Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	649000000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	44000000	USD
CY2018Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	353000000	USD
CY2019Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	124000000	USD
CY2018Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	33000000	USD
CY2019Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2047000000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	482000000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	716000000	USD
CY2018Q1	us-gaap	Payments To Suppliers And Employees PaymentsToSuppliersAndEmployees	4271000000	USD
CY2019Q1	us-gaap	Payments To Suppliers And Employees PaymentsToSuppliersAndEmployees	7403000000	USD
CY2018Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1329000000	USD
CY2019Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	13459000000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2259000000	USD
CY2019Q1	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2582000000	USD
CY2018Q1	us-gaap	Proceeds From Customers ProceedsFromCustomers	43369000000	USD
CY2019Q1	us-gaap	Proceeds From Customers ProceedsFromCustomers	58873000000	USD
CY2018Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	725000000	USD
CY2019Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2018Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	50000000	USD
CY2019Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	250000000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	39376000000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5000000	USD
CY2018Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1276000000	USD
CY2019Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	2285000000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10000000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1986000000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	107000000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	101000000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	998000000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	1427000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11349000000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11348000000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11360000000	USD
CY2018Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2019Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	59000000	USD
CY2018Q4	us-gaap	Reinsurance Recoverables On Unpaid Losses Gross ReinsuranceRecoverablesOnUnpaidLossesGross	4000000	USD
CY2019Q1	us-gaap	Reinsurance Recoverables On Unpaid Losses Gross ReinsuranceRecoverablesOnUnpaidLossesGross	5000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58543000000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60006000000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58721000000	USD
CY2019Q1	us-gaap	Sublease Income SubleaseIncome	12000000	USD
CY2018Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	22000000	USD
CY2019Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	10000000	USD
CY2018Q1	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	35000000	USD
CY2019Q1	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	25000000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	882000000	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	6000000	USD
CY2019Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	6000000	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	230000000	USD
CY2019Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	266000000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	40911000000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41859000000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41089000000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45693000000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61397000000	USD
CY2018Q1	us-gaap	Revenues Revenues	45743000000	USD
CY2019Q1	us-gaap	Revenues Revenues	61646000000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	12000000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	556000000	USD
CY2019Q1	us-gaap	Sale Leaseback Transaction Net Proceeds Investing Activities SaleLeasebackTransactionNetProceedsInvestingActivities	5000000	USD
CY2018Q4	us-gaap	Separate Account Assets SeparateAccountAssets	3884000000	USD
CY2019Q1	us-gaap	Separate Account Assets SeparateAccountAssets	4074000000	USD
CY2018Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3884000000	USD
CY2019Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4074000000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	55000000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	114000000	USD
CY2018Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	720000000	USD
CY2019Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	3005000000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	2522000000	USD
CY2019Q1	us-gaap	Short Term Investments ShortTermInvestments	2426000000	USD
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6000000	USD
CY2019Q1	us-gaap	Shortduration Insurance Contracts Incurred But Not Reported Ibnr Claims Liability Net ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet	5100000000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	112000000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	175000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	13900000000	USD
CY2018Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2019Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	58225000000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	59686000000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	58403000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-37695000000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-38677000000	USD
CY2019Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	13804000000	USD
CY2019Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	446000000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	425000000	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	424000000	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	28228000000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	28221000000	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	142000000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1019000000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1302000000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1016000000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1298000000	shares

Files In Submission

Name	View Source	Status
0000064803-19-000021-index-headers.html	Edgar Link	pending
0000064803-19-000021-index.html	Edgar Link	pending
0000064803-19-000021.txt	Edgar Link	pending
0000064803-19-000021-xbrl.zip	Edgar Link	pending
certificationex311-03312019.htm	Edgar Link	pending
certificationex312-30312019.htm	Edgar Link	pending
certificationex321-30312019.htm	Edgar Link	pending
certificationex322-30312019.htm	Edgar Link	pending
cvs-20190331.xml	Edgar Link	completed
cvs-20190331.xsd	Edgar Link	pending
cvs-20190331x10q.htm	Edgar Link	pending
cvs-20190331_cal.xml	Edgar Link	unprocessable
cvs-20190331_def.xml	Edgar Link	unprocessable
cvs-20190331_lab.xml	Edgar Link	unprocessable
cvs-20190331_pre.xml	Edgar Link	unprocessable
cvshealtha08.jpg	Edgar Link	pending
ex101.htm	Edgar Link	pending
ex102.htm	Edgar Link	pending
ex103.htm	Edgar Link	pending
ex104.htm	Edgar Link	pending
ex151.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVS
CVS HEALTH Corp Stock $cvs

2019 Q1 Form 10-Q Financial Statement

#000006480319000021 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVS CVS HEALTH Corp Stock $cvs

2019 Q1 Form 10-Q Financial Statement

#000006480319000021 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVS
CVS HEALTH Corp Stock $cvs